The suit is expected to impact Natco Pharma, Dr Reddy#39;s Labs, Cipla, and Zydus Lifesciences. All these companies had launched Revlimid during the second COVID-19 wave in September 2021
The suit is expected to impact Natco Pharma, Dr Reddy#39;s Labs, Cipla, and Zydus Lifesciences. All these companies had launched Revlimid during the second COVID-19 wave in September 2021
हिन्दी 
English